Caixin
Apr 28, 2022 08:00 AM

Betta Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 45.9% in First Quarter of 2022

Betta Pharmaceuticals Co.,Ltd. (贝达药业股份有限公司) (300558.SZ) reported a net profit of 79.3 million yuan in the first quarter of 2022, down 45.9% year-on-year.

Meanwhile, the company posted 584.7 million yuan in revenue, down 5.5% year-on-year.

At the end of the reporting period, it had 6.6 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 27.2%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin Deep Dive: Why Singapore Sovereign Fund Sues Chinese EV-Maker Nio
00:00
00:00/00:00